CAPRICOR THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $-7.2M | $2.8M |
| Jun 2017 | — | $-6.6M | $8.3M |
| Sep 2017 | — | $-4.3M | $8.9M |
| Dec 2017 | — | $11.2M | $6.1M |
| Mar 2018 | — | $10.5M | $7.2M |
| Jun 2018 | — | $9.6M | $6.3M |
| Sep 2018 | — | $7.0M | $4.4M |
| Dec 2018 | — | $4.6M | $4.3M |
| Mar 2019 | — | $3.7M | $7.2M |
| Jun 2019 | — | $2.4M | $5.9M |
| Sep 2019 | — | $3.6M | $6.8M |
| Dec 2019 | — | $6.8M | $3.9M |
| Mar 2020 | — | $9.6M | $13.2M |
| Jun 2020 | — | $31.7M | $36.3M |
| Sep 2020 | — | $30.4M | $35.3M |
| Dec 2020 | — | $28.2M | $32.7M |
| Mar 2021 | — | $36.4M | $41.9M |
| Jun 2021 | — | $33.4M | $38.1M |
| Sep 2021 | — | $36.7M | $40.8M |
| Dec 2021 | — | $31.4M | $34.9M |
| Mar 2022 | — | $24.6M | $58.3M |
| Jun 2022 | — | $18.7M | $16.4M |
| Sep 2022 | — | $15.4M | $8.4M |
| Dec 2022 | — | $11.8M | $9.6M |
| Mar 2023 | — | $6.2M | $10.6M |
| Jun 2023 | — | $2.7M | $9.8M |
| Sep 2023 | — | $-1.8M | $9.0M |
| Dec 2023 | — | $22.6M | $14.7M |
| Mar 2024 | — | $18.4M | $6.2M |
| Jun 2024 | — | $11.5M | $10.7M |
| Sep 2024 | — | $68.3M | $68.4M |
| Dec 2024 | — | $145.5M | $11.3M |
| Mar 2025 | — | $127.6M | $28.8M |
| Jun 2025 | — | $105.0M | $23.2M |
| Sep 2025 | — | $83.9M | $19.5M |
| Dec 2025 | — | $305.8M | $287.8M |
| Mar 2026 | — | $278.7M | $105.4M |
| Jun 2026 | — | $246.2M | $20.9M |